Back

Role of six-minute walk test as a risk stratification tool in patients undergoing surgery for secondary ischemic mitral regurgitation

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Shock, decompensation, and acute heart failure Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Michele D'Alonzo

ASST Papa Giovanni XXIII Bergamo, Bergamo (Italy)

6 More presentations in this session

Presentation thumbnail
Age related differences in clinical phenotype, care and outcomes in ambulance attended acute heart failure: a population-based cohort study
Doctor M. Rubinstein (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
First 24-hour diuresis as a prognostic marker in cardiogenic shock
Doctor L. Bacmeister (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of frailty and exercise capacity in patients with acute decompensated heart failure and preserved ejection fraction in relation to MAGGIC Score ~PURSUIT-HFpEF Registry~
Doctor T. Kondo (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Therapy optimization and 1-year outcomes in cardiogenic shock: insights from the ENIGMA-shock initiative
Doctor G. Guarnieri (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Early intensive inpatient cardiac rehabilitation in heart failure: the CardioRehab Registry Experience
Doctor A. Gianmatteo (Pavia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Shock, decompensation, and acute heart failure

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Session
Estimating prognosis after atrial ventricular: valvular intervention
31 August 2025
thumbnail
Congress Presentation
Global myocardial work index is an independent predictor of functional capacity on 6-minute walk test in stable non-ischaemic cardiomyopathy
1 September 2024
thumbnail
Congress Presentation
Distinct features of predictive profiles for poor functional improvement and mortality after TAVR. Incremental value of 6-minute walk test
30 August 2025
thumbnail
Congress Presentation
Prognostic importance of the 6-minute walk test in transthyretin cardiac amyloidosis
13 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources